CDK2 and lung carcinoma: It has recently been shown that CDK2 is targetable, and seliciclib (CYC202), a CDK2/7/9 inhibitor, induces apoptosis in lung cancer cells with supernumerary centrosomes through multipolar anaphase, which is termed anaphase catastrophe.33